Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01
Published October 15, 2014 · Recall initiated: September 15, 2014
Summary
FDA records drug Class II recall D-0008-2015, published October 15, 2014 and initiated September 15, 2014. Recalling firm: Astellas Pharma US Inc; Status: Terminated; Reported quantity: 9,236 bottles; Lot: Lot 66482CW, Exp 04/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Astellas Pharma US Inc
- Distributor
- Nationwide
- Lot
- Lot 66482CW, Exp 04/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd.October 15, 2014
- FDAMetoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by MylanOctober 15, 2014
- FDAXarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PROctober 15, 2014
- FDAMETOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. ManufacturedOctober 15, 2014
- FDAAmiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for MylanOctober 15, 2014
- FDAAmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only,July 31, 2013
Questions about this recall
Was Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01 recalled?
Yes. FDA published recall D-0008-2015 on October 15, 2014. Reported hazard: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter